297,763 Shares in Helen of Troy Limited $HELE Acquired by Hsbc Holdings PLC

Key Points

• Hsbc Holdings PLC acquired 297,763 shares of Helen of Troy, valued at approximately $8.5 million, giving it a 1.28% stake. Other institutional investors, including Paradigm Capital and RWWM, also increased their positions.
• Analyst sentiment remains mixed, with one Strong Buy, three Holds and one Sell rating. The consensus rating is Hold, with an average price target of $26.50.
• Helen of Troy exceeded quarterly expectations, reporting $0.17 EPS versus a $0.02 estimate and revenue of $402.12 million versus $374.55 million expected. Revenue increased 8.2% year over year, despite a negative net margin of 22.70%.

Hsbc Holdings PLC purchased a new position in shares of Helen of Troy Limited (NASDAQ:HELE - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 297,763 shares of the company's stock, valued at approximately $8,507,000. Hsbc Holdings PLC owned approximately 1.28% of Helen of Troy as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Paradigm Capital Management Inc. NY boosted its holdings in shares of Helen of Troy by 64.3% in the first quarter. Paradigm Capital Management Inc. NY now owns 927,100 shares of the company's stock valued at $13,369,000 after purchasing an additional 362,900 shares during the period. Renaissance Technologies LLC purchased a new position in Helen of Troy during the 1st quarter worth $571,000. RWWM Inc. raised its position in Helen of Troy by 85.7% during the 1st quarter. RWWM Inc. now owns 1,173,829 shares of the company's stock valued at $16,927,000 after purchasing an additional 541,689 shares in the last quarter. Wedge Capital Management L L P NC bought a new stake in Helen of Troy during the 2nd quarter valued at $1,532,000. Finally, Invenomic Capital Management LP lifted its holdings in shares of Helen of Troy by 6.9% in the 4th quarter. Invenomic Capital Management LP now owns 593,310 shares of the company's stock worth $12,608,000 after buying an additional 38,325 shares during the period.

Analyst Upgrades and Downgrades

HELE has been the topic of a number of recent research reports. Wall Street Zen raised Helen of Troy from a "hold" rating to a "strong-buy" rating in a research report on Sunday, July 12th. Canaccord Genuity Group lifted their price objective on Helen of Troy from $23.00 to $25.00 and gave the company a "hold" rating in a report on Thursday, July 9th. Weiss Ratings lowered shares of Helen of Troy from a "sell (d)" rating to a "sell (d-)" rating in a research note on Tuesday, July 21st. Zacks Research downgraded shares of Helen of Troy from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 6th. Finally, UBS Group boosted their price target on shares of Helen of Troy from $25.00 to $28.00 and gave the company a "neutral" rating in a report on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $26.50.

Helen of Troy Trading Down 1.0%

HELE opened at $28.62 on Friday. The firm has a market cap of $666.56 million, a price-to-earnings ratio of -1.59 and a beta of 1.31. The company has a current ratio of 1.78, a quick ratio of 0.81 and a debt-to-equity ratio of 0.82. Helen of Troy Limited has a 12 month low of $13.85 and a 12 month high of $30.68. The stock has a fifty day moving average price of $28.27 and a 200-day moving average price of $23.20.

Helen of Troy (NASDAQ:HELE - Get Free Report) last issued its quarterly earnings data on Wednesday, July 8th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.15. The firm had revenue of $402.12 million for the quarter, compared to the consensus estimate of $374.55 million. Helen of Troy had a negative net margin of 22.70% and a positive return on equity of 6.46%. The company's quarterly revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.41 EPS. Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. As a group, equities research analysts anticipate that Helen of Troy Limited will post 2.84 earnings per share for the current fiscal year.

Helen of Troy Profile

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source